4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0000899243-18-020661
Options or other derivatives
- Chief Scientific Officer acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Scientific Officer | 2018-07-24 | Grant or award · Restricted Stock Units | +45,000 | 49,688 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…